Moreover, PIK3CB mutation and amplification is significantly enriched in tumors with FOXP1-SHQ1 deletion (P = 0.002, Fisher’s exact test) in the TCGA prostate cancer cohort, which has available exome sequencing data (Supplementary Table 1). This evidence concerns the gene PIK3CB and Familial prostate cancer.